Compounded Bioidentical Hormone Therapy Market Share

Regionally, the global compounded bioidentical hormone therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The global market in the North America industry is estimated to account for largest revenue share by 2036, on the back of higher healthcare expenditure, increasing thyroid prevalence amongst women, and more awareness amongst the people. According to a report by American Thyroid Association, one in eight women will develop a thyroid disorder during her lifetime. Furthermore, scientists are proactive to find out remedies for menopause-related issues, which is the reason the global compounded bioidentical hormone therapy is expected to propel over the forecast period.

The Europe region is also projected to witness considerable growth in the compounded bioidentical hormone therapy market over the forecast period owing to the higher disposable income of people, and robust healthcare infrastructure.